MDS Pharma Services offers efficacy disease models in the following therapeutic areas:
- Cardiovascular
- Oncology
- Gastrointestinal
- Metabolic
- Renal/Urogenital
- Central Nervous System
- Acute and Chronic Pain
- Inflammation
- Metabolic Bone
- Orthopedics & Tissue Engineering
With the acquisition of SkeleTech, Inc. in August, 2005, MDS Pharma Services expanded our (proof-of-concept) (efficacy disease models) to include expertise in bone and central nervous system (CNS) efficacy pharmacology.
|